U.S. Professional Services Stock News

NYSE:SO
NYSE:SOElectric Utilities

The Bull Case For Southern (SO) Could Change Following Its 25th Straight Dividend Hike - Learn Why

Southern Company recently declared a regular quarterly dividend of US$0.76 per share, payable on June 8, 2026, to shareholders of record on May 18, 2026, raising its annualized payout by US$0.08 to US$3.04 per share. This latest increase marks Southern Company’s 25th consecutive annual dividend raise, highlighting a long-running emphasis on consistent and growing cash returns for income-focused investors. We’ll now examine how this 25th consecutive dividend increase, alongside Southern’s...
NYSE:HUM
NYSE:HUMHealthcare

Does Humana’s (HUM) New Fulfillment Index Reframe Its Senior-Care Edge Beyond Traditional Clinical Metrics?

In April 2026, Humana Inc. held its annual shareholder meeting, filed a US$2.14 billion ESOP-related shelf registration for common stock, affirmed a US$0.885 quarterly dividend, elected healthcare investor Robert S. Field to its board, and saw CenterWell launch the 72-indicator Fulfillment Index to better measure wellbeing in older adults. Together, these moves highlight Humana’s twin focus on governance and workforce incentives, while CenterWell’s Fulfillment Index underscores a broader...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Honeywell International (HON) Margin Compression Challenges Bullish Earnings Narratives Ahead Of Q1 2026

Honeywell International (HON) has put fresh numbers on the table for Q1 2026, with Q4 2025 revenue at US$9.8 billion and basic EPS of US$0.49 setting the tone for how investors are reading the current US$214.34 share price. Over the recent quarters, the company has seen revenue move from US$9.6 billion in Q2 2024 to US$9.7 billion in Q3 2024 and then to US$9.8 billion in Q4 2025. Quarterly basic EPS shifted from US$2.37 to US$2.17 to US$2.24 and then US$2.46 before the latest Q4 figure,...
NYSE:SES
NYSE:SESElectrical

Assessing SES AI (SES) Valuation After Q1 Revenue Jump And Energy Storage Progress

Why SES AI (SES) is back on investors’ radar SES AI (SES) is drawing fresh attention after reporting first quarter 2026 revenue of US$6.7 million, a 47% sequential increase, while reaffirming full year guidance of US$30 million to US$35 million. See our latest analysis for SES AI. Despite the Q1 revenue update and new agreements in energy storage and drone cells, SES AI’s share price has had a mixed run, with a 16.19% 1 month share price return but a 36.46% year to date share price decline...
NYSE:DCOM
NYSE:DCOMBanks

Dime Community Bancshares (DCOM) Margin Rebound Challenges Longer Term Earnings Decline Narrative

Dime Community Bancshares (DCOM) Q1 2026 results in focus Dime Community Bancshares (DCOM) has just reported its Q1 2026 results with recent quarterly revenue most recently at about US$112.9 million in Q4 2025, basic EPS at US$0.67 and trailing twelve month EPS at US$2.36, set against a very large 373.9% reported earnings growth over the past year. Over the last six reported quarters, revenue has ranged from US$43.5 million in Q4 2024 to US$112.9 million in Q4 2025, while quarterly EPS has...
NYSE:REX
NYSE:REXOil and Gas

A Look At REX American Resources (REX) Valuation After Proposed Authorized Share Increase

Why the share authorization proposal matters for REX American Resources (REX) REX American Resources (REX) plans to ask shareholders on May 28, 2026 to approve an increase in authorized common stock from 45,000,000 to 90,000,000 shares. This type of authorization change can give the company more flexibility for potential future capital raising, stock-based transactions, or corporate actions. This is why it often becomes a focal point for existing and prospective shareholders. See our latest...
NYSE:KKR
NYSE:KKRCapital Markets

A Look At KKR’s (KKR) Valuation As Recent Performance And Earnings Trends Diverge

Recent share performance and business snapshot KKR (KKR) has drawn attention after mixed recent returns, with the stock down about 10% over the past year yet higher over the past 3 months and in the past month. At a last close of US$101.64, KKR shows a 3 year total return a little above 100% and 5 year total return below that level, while year to date performance reflects a decline of about 21%. The firm reports annual revenue of US$25.65b and net income of US$2.24b, with revenue and net...
NYSE:ARR
NYSE:ARRMortgage REITs

Armour Residential REIT (ARR) Heads Into Q1 2026 With Volatile Revenue And EPS Swings

ARMOUR Residential REIT (ARR) opened its latest earnings season update with investors focused on how its recent results line up with a year of shifting quarterly EPS and revenue, including Q4 2025 revenue of about US$225.7 million and EPS of US$1.86. Over the past six reported quarters, revenue has ranged from a loss of US$61.3 million in Q2 2025 to US$225.7 million in Q4 2025, while EPS has swung between a loss of US$0.94 and a gain of US$1.86. This sets up this quarter’s release as a check...
NasdaqGS:GNTX
NasdaqGS:GNTXAuto Components

Gentex (GNTX) Is Up 5.5% After Q1 2026 Revenue And EPS Beat - What's Changed

Gentex Corporation recently reported first-quarter 2026 results, with sales rising to US$675.44 million from US$576.77 million and net income increasing to US$98.46 million from US$94.87 million a year earlier, while basic and diluted earnings per share from continuing operations moved to US$0.46 from US$0.42. The combination of stronger revenue and higher earnings per share points to improved operating performance versus the prior year’s quarter, providing fresh context for how Gentex’s...
NasdaqGM:TTD
NasdaqGM:TTDMedia

Is It Time To Reassess Trade Desk (TTD) After A 57.5% One Year Share Price Fall

If you are wondering whether Trade Desk's current share price reflects its true worth, this article walks through the key numbers that matter for you as a long term investor. The stock last closed at US$22.62, with returns of 1.3% over 30 days, but declines of 40.0% year to date and 57.5% over the past year that may have changed how the market views its risk and potential. Recent coverage has focused on how Trade Desk fits within the broader media and advertising technology space and how...
NYSE:XYZ
NYSE:XYZDiversified Financial

Is It Time To Reassess Block (SQ) After Its Mixed Five Year Share Price Performance?

Wondering whether Block is attractively priced at its current level, or if the recent run has already baked in the opportunity. The share price last closed at US$69.93, with returns of 1.8% over 7 days, 16.8% over 30 days, 7.3% year to date, 21.6% over 1 year and a 71.8% decline over 5 years. This gives a mixed picture of how the market has treated the stock. Recent news coverage has focused on Block's position as a major listed name in the diversified financials space and its role in...
NYSE:PHM
NYSE:PHMConsumer Durables

PulteGroup (PHM) Margin Compression To 12.8% Tests Bullish Earnings Narrative

PulteGroup (PHM) has just opened the books on Q1 2026 with investors looking back at recent quarters where quarterly revenue moved from US$4.9b in Q4 2024 to US$4.6b in Q4 2025 and basic EPS shifted from US$4.47 to US$2.58 as net income moved from US$913.2 million to US$501.6 million. Over the same stretch, trailing twelve month revenue moved in a tight band around US$17.3b to US$18.0b while trailing EPS eased from US$14.82 to US$11.21, which sets up this new quarter against a backdrop of...
NYSE:EME
NYSE:EMEConstruction

Is EMCOR Group’s (EME) Inter Miami Stadium Win a Hint About Its Next Profit Engine?

Earlier this week, Hill York Service Company, an EMCOR Group subsidiary, announced it had delivered the state-of-the-art HVAC and mechanical systems package for Inter Miami CF’s new 26,700-seat Nu Stadium in Miami, becoming its official HVAC provider. This high-profile stadium project underscores EMCOR’s capacity to handle complex, multi-trade, large-scale installations that can reinforce its position in mission-critical and specialty mechanical work. Next, we’ll examine how this flagship...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Interim CFO Return Puts Acadia Healthcare Leadership Stability In Focus

Acadia Healthcare Company (NasdaqGS:ACHC) has appointed David Duckworth as Interim CFO, replacing outgoing CFO Todd Young. Duckworth returns to the role after nearly a decade of prior service as Acadia's CFO. The transition occurs while the company continues its search for a permanent CEO. Acadia Healthcare shares recently closed at $27.34, with the stock up 20.5% over the past 30 days and 1.7% over the past week. Over a longer horizon, returns have been mixed, with a 91.3% return year to...
NYSE:NVO
NYSE:NVOPharmaceuticals

Assessing Novo Nordisk (NYSE:NVO) Valuation As Recent Returns Show Signs Of Fading Momentum

Recent performance context for Novo Nordisk Novo Nordisk (NYSE:NVO) has been trading around $38.52, with a 1 day return of about 1.6% and a past week move near 5.9%, as investors weigh its broader performance trends. See our latest analysis for Novo Nordisk. While the recent 7 day share price return of about 5.9% contrasts with a 90 day share price return of roughly 38% and a 1 year total shareholder return of around 36%, the pattern points to fading momentum after a stronger stretch earlier...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Is Magnite (MGNI) Quietly Redefining CTV Scale With Its Hearst And AMC Integrations?

In mid-April 2026, Magnite announced expanded collaborations with Hearst News and AMC Global Media to power high-impact web, CTV, and live-streaming ad formats using its SpringServe, ClearLine, and Live Scheduler platforms. These partnerships highlight how Magnite is embedding its technology deeper into premium news and entertainment ecosystems, giving advertisers streamlined access to large, highly engaged audiences across linear TV, streaming, and digital video. Next, we’ll examine how...
NYSE:KSS
NYSE:KSSMultiline Retail

Kohl's (KSS) Is Up 5.1% After Securing A $550 Million Tariff Refund Windfall - What's Changed

Kohl's recently disclosed that it will receive a US$550 million refund for tariffs it had previously paid, providing a one-time boost to its reported revenue and earnings. This unexpected tariff refund arrives against a backdrop of earlier guidance for weaker earnings and softer sales, materially improving Kohl's near-term financial flexibility. Next, we’ll examine how this sizable tariff refund reshapes Kohl’s investment narrative, including its margin outlook and balance sheet...
NYSE:AWK
NYSE:AWKWater Utilities

A Look At American Water Works Company (AWK) Valuation After Recent Share Price Momentum

What recent performance says about American Water Works Company American Water Works Company (AWK) has drawn investor attention after a recent share price move, with the stock up about 3% over the past week and roughly 1% over the past month. That follows a year where the total return sits near a 5% decline, even as year-to-date performance is about 3.6% and the past 3 months show roughly a 4.1% gain, prompting closer scrutiny of fundamentals. See our latest analysis for American Water Works...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Is Webull (BULL) Pricing Make Sense After Recent Volatility And DCF Estimate?

Wondering whether Webull's share price reflects its true worth, or if the market is mispricing it? This article walks through the key valuation angles you need to see for yourself. Webull's stock last closed at US$6.91, with returns of 6.6% over the past week and 34.7% over the past month, while the 1 year return sits at a loss of 64.6%. Recent headlines around Webull have focused on the stock's sharp swings and what that might imply for investor sentiment and risk appetite. These moves put...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics (TGTX) Is Up 7.6% After Advancing Subcutaneous BRIUMVI Phase 3 Trial Enrollment Completion

TG Therapeutics recently completed enrollment in a Phase 3 trial of a subcutaneous formulation of BRIUMVI for adults with relapsing multiple sclerosis, comparing every 8- and 12-week dosing to the currently approved intravenous regimen on pharmacokinetics, safety, and clinical outcomes. A key focus of the study is whether subcutaneous BRIUMVI can match the drug exposure of the intravenous form while potentially offering a more convenient administration schedule and expanding its clinical...
NYSE:WRB
NYSE:WRBInsurance

New Berkley Environmental Leader Puts Focus On Underwriting And Growth Narrative

W. R. Berkley (NYSE:WRB) has appointed R. Christopher DeLauder as president of Berkley Environmental. The move reflects an internal promotion within a key specialty unit focused on environmental insurance. The leadership change signals a new point person for underwriting, risk focus, and execution inside this subsidiary. The appointment at Berkley Environmental comes as W. R. Berkley shares trade around $68.45, with returns of 3.3% over the past week and 5.3% over the past month. Over a...
NYSE:SYF
NYSE:SYFConsumer Finance

Synchrony Financial Expands Into Women’s Apparel With New Loyalty Suite

Synchrony Financial (NYSE:SYF) has rolled out a co-branded credit card and digital loyalty suite with Chico's, White House Black Market, and Soma. The launch introduces a unified rewards ecosystem across the Chico's FAS brands, focused on women's apparel and lifestyle shoppers. The new products use Synchrony’s PRISM credit decisioning technology to support both in store and digital customer experiences. For investors watching NYSE:SYF, this move comes as the shares trade at $76.62, with a 1...
NYSE:AEM
NYSE:AEMMetals and Mining

A Look At Agnico Eagle Mines (AEM) Valuation After Recent Share Price Swings

Why Agnico Eagle Mines is on investors’ radar today Agnico Eagle Mines (NYSE:AEM) is back in focus after recent share price swings, with a 1 day return of 2.5% decline contrasted with a month gain of 8.4% and a past 3 months decline of 7.3%. For investors watching gold producers, that mixed return profile sits alongside reported annual revenue of US$11.91b and net income of US$4.46b, providing a sense of the company’s current scale and profitability. See our latest analysis for Agnico Eagle...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Assessing Nurix Therapeutics (NRIX) Valuation After New AACR 2026 Oncology Data

Nurix Therapeutics (NRIX) put its oncology pipeline in focus at the AACR 2026 Annual Meeting, releasing new preclinical data on its pan mutant BRAF, CBL B, and Aurora Kinase A degrader programs. See our latest analysis for Nurix Therapeutics. Nurix’s latest AACR data drop comes after a mixed share price run, with a 14.75% 1 month share price return but a 1 year to date share price decline of 8.25%, while the 1 year total shareholder return sits at 43.84%, hinting at shifting expectations...